Clinical Treatment of Vitreoretinal Disorders: Current Updates and Perspectives

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 1434

Special Issue Editor


E-Mail Website
Guest Editor
Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
Interests: vitreoretinal disorder; vitrectomy; digital assisted vitrectomy; intraoperative optical coherence tomography; diabetic retinopathy; epiretinal membrane

Special Issue Information

Dear Colleagues,

In recent years, vitreoretinal surgery has seen exponential advancements, largely attributed to the development of surgical instruments, ancillary equipment, and the introduction of numerous new surgical techniques. As a result, expectations regarding surgical outcomes and postoperative visual functions have risen. Surgeons are increasingly expected to successfully complete even the most intricate and demanding surgeries with precision and finesse. To meet these escalating expectations, it is imperative not only to enhance the surgeon's individual skills but also to master the use of surgical instruments and ancillary equipment. Additionally, the flexibility to adopt and implement new techniques that leverage these tools is crucial. Therefore, this Special Issue aims to explore the future of vitreoretinal surgery, and we widely encourage authors to submit articles related to the following topics: (a) examination of new techniques in vitreoretinal surgery; (b) novel clinical approaches in vitreoretinal surgery using heads-up surgery; (c) novel clinical approaches to vitreoretinal surgery using intraoperative OCT; (d) new insights and clinical approaches regarding surgical instruments and peripheral devices; and (e) other reports related to vitreoretinal surgery.

Prof. Dr. Hisanori Imai
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vitrectomy
  • digital assisted vitrectomy
  • heads-up surgery
  • intraoperative optical coherence tomography
  • minimally invasive vitreoretinal surgery

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

22 pages, 717 KiB  
Review
Recent Advances of Adipose-Tissue-Derived Mesenchymal Stem Cell-Based Therapy for Retinal Diseases
by Lucia Finocchio, Marco Zeppieri, Andrea Gabai, Leopoldo Spadea and Carlo Salati
J. Clin. Med. 2023, 12(22), 7015; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm12227015 - 09 Nov 2023
Cited by 1 | Viewed by 1259
Abstract
With the rapid development of stem cell research in modern times, stem cell-based therapy has opened a new era of tissue regeneration, becoming one of the most promising strategies for currently untreatable retinal diseases. Among the various sources of stem cells, adipose tissue-derived [...] Read more.
With the rapid development of stem cell research in modern times, stem cell-based therapy has opened a new era of tissue regeneration, becoming one of the most promising strategies for currently untreatable retinal diseases. Among the various sources of stem cells, adipose tissue-derived mesenchymal stem cells (ADSCs) have emerged as a promising therapeutic modality due to their characteristics and multiple functions, which include immunoregulation, anti-apoptosis of neurons, cytokine and growth factor secretion, and antioxidative activities. Studies have shown that ADSCs can facilitate the replacement of dying cells, promote tissue remodeling and regeneration, and support the survival and growth of retinal cells. Recent studies in this field have provided numerous experiments using different preclinical models. The aim of our review is to provide an overview of the therapeutic strategies, modern-day clinical trials, experimental models, and potential clinical use of this fascinating class of cells in addressing retinal disorders and diseases. Full article
Show Figures

Graphical abstract

Back to TopTop